Search Results - "Simuni T"

Clinical Vignettes in Parkinson's Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive Behaviours.

Authors: Friedman, Joseph H. Agarwal, P. Alcalay, R. et al.

Source: International Journal of Neuroscience. Aug2011, Vol. 121 Issue 8, p472-476. 5p.

Subjects: Parkinson's disease treatment, Drug side effects, Disease complications, Compulsive behavior, Delusions, Hallucinations, Neurologists, Psychiatrists

Does Levodopa Accelerate Parkinson's Disease?

Authors: Simuni, T. Stern, M.B.

Source: Drugs & Aging. 1999, Vol. 14 Issue 6, p399-408. 10p.

P2.161 STEADY-PD: safety, tolerability, and efflcacy assessment of isradipine (Dynacirc CR) in early Parkinson disease

Authors: Simuni, T. Biglan, K. Oakes, D. et al.

Source: Parkinsonism & Related Disorders. Dec2009 Supplement 2, Vol. 15, pS133-S133. 1p.

Nonmotor manifestations of Parkinson's disease.

Authors: Simuni T Sethi K

Source: Annals of Neurology. Aug2008 Supplement, pS65-80. 1p.

Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.

Authors: Chahine, L.M. Xie, S.X. Simuni, T. et al.

Source: Parkinsonism & Related Disorders. Jun2016, Vol. 27, p102-106. 5p.

15.29 Adaptation of step initiation to postural assistance in patients with Parkinson's disease

Authors: Rogers, M.W. Martinez, K.M. Johnson, M.E. et al.

Source: Gait & Posture. Jan2005 Supplement 1, Vol. 21, pS98-S98.

Brain donation - What do patients with movement disorders know and how do they feel about it?

Authors: Kuhta T Zadikoff C Simuni T et al.

Source: Parkinsonism & Related Disorders. Mar2011, Vol. 17 Issue 3, p204-207. 4p.

Trial of Prasinezumab in Early-Stage Parkinson's Disease.

Authors: Pagano, G. Taylor, K. I. Anzures-Cabrera, J. et al.

Source: New England Journal of Medicine. 8/4/2022, Vol. 387 Issue 5, p421-432. 12p.

Hippocampal-sparing Alzheimer's disease presenting as corticobasal syndrome.

Authors: Malkani RG Dickson DW Simuni T

Source: Parkinsonism & Related Disorders. Jun2012, Vol. 18 Issue 5, p683-685. 3p.

Falls during a remote observational Parkinson's disease study: AT-HOME PD2 initial results.

Authors: Auinger, P. Hoyt, A. Eaton, K. et al.

Source: Parkinsonism & Related Disorders. May2025, Vol. 134, pN.PAG-N.PAG. 1p.

Implementing Whole Gene Sequencing and Genetic Counseling Internationally for People with Parkinson's Disease: The PD GENEration Experience.

Authors: Galvelis, K.G. Dini, M. Rao, S. et al.

Source: Parkinsonism & Related Disorders. May2025, Vol. 134, pN.PAG-N.PAG. 1p.

Back to the basics: Regular exercise matters in Parkinson's disease: Results from the National Parkinson Foundation QII Registry study.

Authors: Oguh, O Eisenstein, A Kwasny, M et al.

Source: Parkinsonism & Related Disorders. Nov2014, Vol. 20 Issue 11, p1221-1225. 5p.

Mobility, mood and site of care impact health related quality of life in Parkinson's disease.

Authors: Nutt, J.G. Siderowf, A.D. Guttman, M. et al.

Source: Parkinsonism & Related Disorders. Mar2014, Vol. 20 Issue 3, p274-279. 6p.

Caregiver strain in Parkinson's disease: National Parkinson Foundation Quality Initiative Study.

Authors: Oguh, O. Kwasny, M. Carter, J. et al.

Source: Parkinsonism & Related Disorders. Nov2013, Vol. 19 Issue 11, p975-979. 5p.

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.

Authors: Ravina, B. Puff, M. Siderowf, A. et al.

Source: Journal of Neurology, Neurosurgery & Psychiatry. Jul2005, Vol. 76 Issue 7, p934-939. 6p.

261 POSTURAL PREPARATION AND INITIATION PRIOR TO STEPPING IN PATIENTS WITH PARKINSON'S DISEASE

Authors: Rogers, M. Kennedy, R. Palmer, S. et al.

Source: Parkinsonism & Related Disorders. Feb2010 Supplement 1, Vol. 16, pS74-S75. 0p.

O.002 Piloting the NPF data-driven quality initiative to improve Parkinson's disease management

Authors: Siderowf, A. Nutt, J. O'Conner, G. et al.

Source: Parkinsonism & Related Disorders. Dec2009 Supplement 2, Vol. 15, pS1-S1. 1p.

Carriers of LRRK2 pathogenic variants show a milder, anatomically distinct brain signature of Parkinson's disease.

Authors: Kopal J Vo A Tao Q et al.

Source: Communications medicine [Commun Med (Lond)] 2026 Jan 03; Vol. 6 (1), pp. 71. Date of Electronic Publication: 2026 Jan 03.

Publication Type: Journal Article

Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE

Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson's disease.

Authors: Oosterhof TH Mitchell E Ascherio A et al.

Source: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2026 Jul 14. Date of Electronic Publication: 2026 Jul 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis

Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study.

Authors: Nikolcheva T Pagano G Anzures-Cabrera J et al.

Corporate Authors: Nikolcheva T Pagano G Anzures-Cabrera J et al.

Source: Lancet (London, England) [Lancet] 2026 May 30; Vol. 407 (10544), pp. 2227-2240.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE